MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $669,365 | -41.6% | 41,731 | -15.6% | 0.00% | 0.0% |
| Q2 2023 | $1,145,764 | -52.3% | 49,429 | -52.2% | 0.00% | -66.7% |
| Q1 2023 | $2,401,750 | +217.3% | 103,390 | +98.2% | 0.00% | +200.0% |
| Q4 2022 | $756,885 | -100.0% | 52,163 | -50.8% | 0.00% | -66.7% |
| Q3 2022 | $2,024,693,000 | +321.0% | 106,116 | +300.9% | 0.00% | +200.0% |
| Q2 2022 | $480,905,000 | -34.6% | 26,467 | -9.3% | 0.00% | 0.0% |
| Q1 2022 | $735,689,000 | -51.2% | 29,194 | -46.6% | 0.00% | -50.0% |
| Q4 2021 | $1,507,540,000 | -49.2% | 54,621 | -40.5% | 0.00% | -50.0% |
| Q3 2021 | $2,965,191,000 | +96.0% | 91,830 | +85.6% | 0.00% | +100.0% |
| Q2 2021 | $1,513,160,000 | +24.7% | 49,482 | +24.2% | 0.00% | 0.0% |
| Q1 2021 | $1,212,976,000 | +172.8% | 39,835 | +77.2% | 0.00% | +100.0% |
| Q4 2020 | $444,641,000 | +89.4% | 22,485 | +24.9% | 0.00% | – |
| Q3 2020 | $234,824,000 | +56.9% | 18,008 | +36.5% | 0.00% | – |
| Q2 2020 | $149,643,000 | -77.0% | 13,196 | -71.0% | 0.00% | -100.0% |
| Q1 2020 | $651,062,000 | +11.3% | 45,497 | +111.7% | 0.00% | 0.0% |
| Q4 2019 | $585,173,000 | +38.9% | 21,490 | +46.0% | 0.00% | 0.0% |
| Q3 2019 | $421,376,000 | +29.6% | 14,718 | +25.8% | 0.00% | 0.0% |
| Q2 2019 | $325,109,000 | -43.9% | 11,703 | -33.0% | 0.00% | 0.0% |
| Q1 2019 | $579,772,000 | +879.1% | 17,463 | +757.3% | 0.00% | – |
| Q4 2018 | $59,216,000 | -74.1% | 2,037 | -59.0% | 0.00% | – |
| Q3 2018 | $228,804,000 | +53.1% | 4,974 | +24.4% | 0.00% | – |
| Q2 2018 | $149,405,000 | -79.3% | 3,998 | -83.7% | 0.00% | -100.0% |
| Q1 2018 | $723,029,000 | -28.7% | 24,468 | -17.1% | 0.00% | -50.0% |
| Q4 2017 | $1,013,487,000 | -21.4% | 29,509 | -17.2% | 0.00% | -33.3% |
| Q3 2017 | $1,289,926,000 | -9.0% | 35,653 | -35.0% | 0.00% | -25.0% |
| Q2 2017 | $1,417,867,000 | +19.6% | 54,871 | -11.1% | 0.00% | +33.3% |
| Q1 2017 | $1,185,408,000 | +65.1% | 61,740 | +43.3% | 0.00% | 0.0% |
| Q4 2016 | $718,160,000 | +32.3% | 43,081 | +63.3% | 0.00% | +50.0% |
| Q3 2016 | $542,818,000 | -11.3% | 26,376 | +31.9% | 0.00% | -33.3% |
| Q2 2016 | $611,755,000 | +5.2% | 19,992 | +28.6% | 0.00% | +50.0% |
| Q1 2016 | $581,775,000 | -72.1% | 15,543 | -67.8% | 0.00% | -60.0% |
| Q4 2015 | $2,084,542,000 | +41.4% | 48,298 | +22.8% | 0.01% | +25.0% |
| Q3 2015 | $1,474,613,000 | +24.7% | 39,344 | +13.0% | 0.00% | +33.3% |
| Q2 2015 | $1,182,988,000 | -77.5% | 34,804 | -76.6% | 0.00% | -80.0% |
| Q1 2015 | $5,254,528,000 | +1043.8% | 148,433 | +1000.5% | 0.02% | +650.0% |
| Q4 2014 | $459,401,000 | -35.0% | 13,488 | -26.4% | 0.00% | +100.0% |
| Q3 2014 | $706,985,000 | -29.9% | 18,330 | -29.2% | 0.00% | 0.0% |
| Q2 2014 | $1,007,867,000 | +82.1% | 25,896 | +97.5% | 0.00% | – |
| Q1 2014 | $553,373,000 | +5.5% | 13,110 | -47.6% | 0.00% | – |
| Q4 2013 | $524,584,000 | – | 25,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |